Nightingale Informatix Corporation Receives ONC-ACB Certification by Drummond Group
MARKHAM, ON, Feb. 26, 2013 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or the "Company") (TSX-V: NGH), a cloud- based electronic medical record (EMR) software provider has had Nexia™ EMR v. 1.2 tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program. This EHR software is compliant in accordance with the criteria adopted by the Secretary of the U.S. Department of Health and Human Services.
"This is an important milestone for Nexia™, our next generation product. We look forward to helping our clients achieve meaningful use and qualify for incentive funds under ARRA. This certification is the result of a lot of hard work by our dedicated team of designers, developers and quality assurance testers," says Sam Chebib, President & CEO, Nightingale Informatix Corporation.
Drummond Group's ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology - a key component of the federal government's push to improve clinical care delivery through the adoption and effective use of EHRs by U.S. healthcare providers.
Nexia™ EMR, which met the requirements for Meaningful Use Stage 1 is a multi-tenanted, cloud-based application that was designed from the ground-up to be as easy to use as possible with the goal of zero-based training.
"Right from the start, Nightingale has put an emphasis on the user experience and has engaged client feedback at each step of the design process," continues Chebib, "we have leveraged our 10 years of experience in the market and the demands of thousands of our users to develop a true next generation platform. The result is an application that requires little to no training, runs on any operating system such as Apple, Android and Microsoft and delivers the functions that our clients want in an intuitive manner."
"Leveraging information technology for healthcare initiatives provides the opportunity to deliver a high-level quality of care and efficiency which essentially benefits and enhances the overall patient experience," says Rik Drummond, CEO of the Drummond Group Inc. "We have been testing software for more than a decade and will continue to provide our extensive experience testing and certifying complex systems for multiple industries, as well as ensuring interoperability and security remain key components in the growing healthcare industry."
Nightingale anticipates that it will have achieved certification for Meaningful Use Stage 2 by the end of 2013.
"This Complete EHR is 2011 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments."
Vendor name: Nightingale Informatix Corporation. Date Certified: 01/24/2013. Product Version: Nexia™ EMR 1.2. Certification ID number: 01242013-1750-8. Clinical Quality Measures Certified: NQF0024, NQF0024, NQF0028, NQF0038, NQF0041, NQF0043, NQF0061, NQF0064, NQF0421. Any additional software relied upon to certify: none.
Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected. www.nightingalemd.com
About Drummond Group Inc.
Drummond Group Inc. is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) - designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Authorized Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit http://www.drummondgroup.com or email DGI@drummondgroup.com.
Forward Looking Statement
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully secure customer contracts and the timing of securing such contracts; the ability of Nightingale to complete and successfully integrate its acquisitions on an accretive basis, Nightingale's access to debt and capital facilities, including compliance with current debt arrangements; the existence of present and possible future government regulation; the significant competition that exists in the medical software industry; the early stage of Nightingale's business, and risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding. All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding future trends in healthcare spending, economic conditions affecting Nightingale and North American economies; Nightingale's ability to continue to fund its business, rates of customer defaults, relationships with, and payments to lenders, as well as Nightingale's operating cost structure.
Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Nightingale Informatix CorporationFor further information:
For further information about Nightingale, contact:
Marketing Communications Manager
Nightingale Informatix Corporation
Tel: 416-815-0700 ext. 273